I am a medical oncologist who specializes in treating people with cancers of the colon and rectum. I also care for people with anal squamous cell cancer, carcinoid tumors, and other gastrointestinal tract cancers.
My clinical and laboratory research at Memorial Sloan Kettering center on understanding molecular subsets of colorectal cancer and developing new therapies based on this understanding. My work focuses on colorectal tumors with mutations in the BRAF or RAS genes, and I am leading our clinical trial program for colorectal tumors that harbor BRAF mutations. I both treat patients and perform laboratory research and believe that my experiences in each realm inform my work and make me a better researcher. Ultimately, I aim to use our insights into cancer cell biology to help guide the care of our patients and to develop more rationally designed clinical trials that test mechanism-based therapeutic strategies.
- Clinical Expertise: Colorectal Cancer; Gastrointestinal Malignancies
- Languages Spoken: English
- Education: MD, New York University School of Medicine`
- Residencies: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine; Medical Oncology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Co-Investigated by Rona D. Yaeger
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more